Upgrade to SI Premium - Free Trial

Takeda (TAK)

15.60 +0.15 (0.97%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/30/26)

Latest Headlines

Form 6-K TAKEDA PHARMACEUTICAL For: Jun 05 June 5, 2026 6:30 AM - SEC Filing Form 6-K TAKEDA PHARMACEUTICAL For: Jun 05 June 5, 2026 6:28 AM - SEC Filing Form 6-K TAKEDA PHARMACEUTICAL For: Jun 01 June 1, 2026 6:07 AM - SEC Filing Takeda Pharmaceutical (4502:JP) (TAK) PT Raised to JPY7,900 at Citi May 26, 2026 6:19 AM - StreetInsider Form 6-K TAKEDA PHARMACEUTICAL For: May 26 May 26, 2026 6:14 AM - SEC Filing Form 6-K TAKEDA PHARMACEUTICAL For: May 26 May 26, 2026 6:12 AM - SEC Filing Form 6-K TAKEDA PHARMACEUTICAL For: May 26 May 26, 2026 6:11 AM - SEC Filing Form 6-K TAKEDA PHARMACEUTICAL For: May 26 May 26, 2026 6:11 AM - SEC Filing Form 6-K TAKEDA PHARMACEUTICAL For: May 26 May 26, 2026 6:10 AM - SEC Filing Form SD TAKEDA PHARMACEUTICAL May 22, 2026 11:27 AM - SEC Filing Form 6-K TAKEDA PHARMACEUTICAL For: May 19 May 19, 2026 6:11 AM - SEC Filing Takeda Pharmaceutical (4502:JP) (TAK) PT Lowered to JPY6,400 at Macquarie May 14, 2026 6:28 AM - StreetInsider Form 6-K TAKEDA PHARMACEUTICAL For: May 13 May 13, 2026 6:12 AM - SEC Filing Form 6-K TAKEDA PHARMACEUTICAL For: May 13 May 13, 2026 6:07 AM - SEC Filing Takeda reports revenue decline but maintains profit margins in fiscal 2025 May 13, 2026 5:46 AM - StreetInsider Takeda Announces FY2025 Full Year Results and FY2026 Outlook, Highlighted by Excellent Pipeline Progress and Solid FY2025 Results May 13, 2026 2:38 AM - BizWire Form 3 TAKEDA PHARMACEUTICAL For: Apr 27 Filed by: Smoter Jennifer Marie May 5, 2026 6:32 AM - SEC Filing Takeda reports positive Phase 2/3 trial results for TAK-881 in immune disorder May 4, 2026 8:00 AM - StreetInsider Takeda Announces Positive Topline Results from Pivotal Phase 2/3 Clinical Trial of TAK-881 in Primary Immunodeficiency Disease (PID) May 4, 2026 8:00 AM - BizWire Form 4 TAKEDA PHARMACEUTICAL For: Apr 27 Filed by: Weber Christophe Pierre April 28, 2026 6:12 AM - SEC Filing Form 4 TAKEDA PHARMACEUTICAL For: Apr 27 Filed by: Plump Andrew Stewart April 28, 2026 6:11 AM - SEC Filing Form 4 TAKEDA PHARMACEUTICAL For: Apr 27 Filed by: Pignagnoli Agosti Marcello April 28, 2026 6:11 AM - SEC Filing Form 4 TAKEDA PHARMACEUTICAL For: Apr 27 Filed by: Duprey Lauren Rusckowski April 28, 2026 6:11 AM - SEC Filing Form 4 TAKEDA PHARMACEUTICAL For: Apr 27 Filed by: Ricci Gabriele April 28, 2026 6:11 AM - SEC Filing Form 4 TAKEDA PHARMACEUTICAL For: Apr 27 Filed by: Kim Julie So-Young April 28, 2026 6:11 AM - SEC Filing Form 4 TAKEDA PHARMACEUTICAL For: Apr 27 Filed by: Bitetti Teresa Marie April 28, 2026 6:11 AM - SEC Filing Form 4 TAKEDA PHARMACEUTICAL For: Apr 27 Filed by: Furuta Milano April 28, 2026 6:11 AM - SEC Filing Form 4 TAKEDA PHARMACEUTICAL For: Apr 27 Filed by: Platford Giles Richard April 28, 2026 6:11 AM - SEC Filing Bernstein SocGen Group Upgrades Takeda Pharmaceutical (4502:JP) (TAK) to Outperform April 8, 2026 9:35 AM - StreetInsider Form 3 TAKEDA PHARMACEUTICAL For: Apr 01 Filed by: Greenway Nicola Deidre Petal April 6, 2026 6:20 AM - SEC Filing Form 3 TAKEDA PHARMACEUTICAL For: Apr 01 Filed by: Farajallah Awny Samaan Botros April 6, 2026 6:19 AM - SEC Filing Form 3 TAKEDA PHARMACEUTICAL For: Apr 01 Filed by: Ibrahim Ramy Riad Ahmed April 6, 2026 6:17 AM - SEC Filing Citi Upgrades Takeda Pharmaceutical (4502:JP) (TAK) to Buy April 2, 2026 2:40 AM - StreetInsider Macquarie Reiterates Outperform Rating on Takeda Pharmaceutical (4502:JP) (TAK) March 31, 2026 3:19 AM - StreetInsider Form 6-K TAKEDA PHARMACEUTICAL For: Mar 30 March 30, 2026 6:28 AM - SEC Filing Takeda (TAK) Takeda's zasocitinib shows clear skin results in psoriasis trials March 30, 2026 4:21 AM - StreetInsider Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care March 28, 2026 3:00 PM - BizWire Form 6-K TAKEDA PHARMACEUTICAL For: Mar 26 March 26, 2026 6:08 AM - SEC Filing Form 6-K TAKEDA PHARMACEUTICAL For: Mar 25 March 25, 2026 6:05 AM - SEC Filing Takeda, Lilly rejected by Supreme Court on Actos fraud lawsuit March 23, 2026 9:34 AM - StreetInsider Form 3 TAKEDA PHARMACEUTICAL For: Mar 18 Filed by: Kim Julie So-Young March 18, 2026 6:20 AM - SEC Filing Form 3 TAKEDA PHARMACEUTICAL For: Mar 18 Filed by: Furney Natalie Anne Marie March 18, 2026 6:18 AM - SEC Filing Form 3 TAKEDA PHARMACEUTICAL For: Mar 18 Filed by: Bitetti Teresa Marie March 18, 2026 6:18 AM - SEC Filing Form 3 TAKEDA PHARMACEUTICAL For: Mar 18 Filed by: Pignagnoli Agosti Marcello March 18, 2026 6:17 AM - SEC Filing Form 3 TAKEDA PHARMACEUTICAL For: Mar 18 Filed by: FUJIMORI YOSHIAKI March 18, 2026 6:17 AM - SEC Filing Form 3 TAKEDA PHARMACEUTICAL For: Mar 18 Filed by: Higashi Emiko March 18, 2026 6:17 AM - SEC Filing Form 3 TAKEDA PHARMACEUTICAL For: Mar 18 Filed by: Ricci Gabriele March 18, 2026 6:16 AM - SEC Filing Form 3 TAKEDA PHARMACEUTICAL For: Mar 18 Filed by: Miyabashira Asuka March 18, 2026 6:16 AM - SEC Filing Form 3 TAKEDA PHARMACEUTICAL For: Mar 18 Filed by: Reed Kimberly A. March 18, 2026 6:15 AM - SEC Filing Form 3 TAKEDA PHARMACEUTICAL For: Mar 18 Filed by: Pacheco Rhonda Janice March 18, 2026 6:15 AM - SEC Filing Form 3 TAKEDA PHARMACEUTICAL For: Mar 18 Filed by: Orsinger Michel Bruno March 18, 2026 6:15 AM - SEC Filing Form 3 TAKEDA PHARMACEUTICAL For: Mar 18 Filed by: BUTEL JEAN LUC March 18, 2026 6:13 AM - SEC Filing Form 3 TAKEDA PHARMACEUTICAL For: Mar 18 Filed by: Shannon Elaine Mary March 18, 2026 6:13 AM - SEC Filing Form 3 TAKEDA PHARMACEUTICAL For: Mar 18 Filed by: Tsusaka Miki March 18, 2026 6:12 AM - SEC Filing Form 3 TAKEDA PHARMACEUTICAL For: Mar 18 Filed by: Furuta Milano March 18, 2026 6:12 AM - SEC Filing Form 3 TAKEDA PHARMACEUTICAL For: Mar 18 Filed by: Weber Christophe Pierre March 18, 2026 6:12 AM - SEC Filing Form 3 TAKEDA PHARMACEUTICAL For: Mar 18 Filed by: MARAGANORE JOHN March 18, 2026 6:11 AM - SEC Filing Form 3 TAKEDA PHARMACEUTICAL For: Mar 18 Filed by: Platford Giles Richard March 18, 2026 6:11 AM - SEC Filing Form 3 TAKEDA PHARMACEUTICAL For: Mar 18 Filed by: CLARK IAN T March 18, 2026 6:11 AM - SEC Filing Form 3 TAKEDA PHARMACEUTICAL For: Mar 18 Filed by: GILLIS STEVEN March 18, 2026 6:10 AM - SEC Filing Form 3 TAKEDA PHARMACEUTICAL For: Mar 18 Filed by: Duprey Lauren Rusckowski March 18, 2026 6:09 AM - SEC Filing Form 3 TAKEDA PHARMACEUTICAL For: Mar 18 Filed by: Plump Andrew Stewart March 18, 2026 6:09 AM - SEC Filing Form 3 TAKEDA PHARMACEUTICAL For: Mar 18 Filed by: Hatsukawa Koji March 18, 2026 6:09 AM - SEC Filing Form 3 TAKEDA PHARMACEUTICAL For: Mar 18 Filed by: Iijima Masami March 18, 2026 6:09 AM - SEC Filing Takeda Pharmaceutical (4502:JP) (TAK) PT Raised to JPY6,200 at Citi March 13, 2026 2:12 AM - StreetInsider Takeda Pharmaceutical (4502:JP) (TAK) PT Raised to JPY6,700 at Nomura/Instinet March 12, 2026 5:18 AM - StreetInsider Full Article List